Magnetic resonance cell-tracking studies: Spectrophotometry-based method for the quantification of cellular iron content after loading with superparamagnetic iron oxide nanoparticles

Molecular Imaging

Volumn 10, Issue 4, 2011, Pages 270-277

  Böhm, Ingrid ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ABSORPTION SPECTROPHOTOMETRY; CELL TRACKING; CLINICAL APPLICATION; HIGHLY SENSITIVE; IRON CONCENTRATIONS; IRON CONTENT; LABELED CELLS; LIMIT OF DETECTION; LIMIT OF QUANTIFICATIONS; MAGNETIC RESONANCE TOMOGRAPHY; PEAK WAVELENGTH; PRUSSIAN BLUE; SIGNAL INTENSITIES; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLES; SUPERPARAMAGNETICS; USER-FRIENDLY TOOL; WHITE BLOOD CELLS; WHOLE-BODY;

ABSORPTION; ABSORPTION SPECTROSCOPY; ATOMIC ABSORPTION SPECTROMETRY; BLOOD; CELLS; COMPUTERIZED TOMOGRAPHY; IRON; MAGNETIC RESONANCE IMAGING; NANOMAGNETICS; NANOPARTICLES; RESONANCE; SPECTROPHOTOMETRY; SUPERPARAMAGNETISM;

IRON OXIDES;

DEXTRAN; IRON; MAGNETITE NANOPARTICLE; SUPERPARAMAGNETIC IRON OXIDE;

ARTICLE; CHEMISTRY; CYTOLOGY; HUMAN; MAGNETISM; METABOLISM; METHODOLOGY; MONONUCLEAR CELL; NUCLEAR MAGNETIC RESONANCE IMAGING; SPECTROSCOPY; STANDARD;

DEXTRANS; HUMANS; IRON; LEUKOCYTES, MONONUCLEAR; MAGNETIC RESONANCE IMAGING; MAGNETICS; MAGNETITE NANOPARTICLES; SPECTRUM ANALYSIS;

EID: 79959715453     PISSN: 15353508     EISSN: None     Source Type: Journal    
DOI: 10.2310/7290.2010.00039     Document Type: Article

References (24)

1. Weissleder R, Cheng HC, Bogdanova A, Bogdanov A Jr. Magnetically labeled cells can be detected by MR imaging. J Magn Reson Imaging 1997;7:258-63. (Pubitemid 28365670)
2. Alfke H, Stoppler H, Nocken F, et al. In vitro MR imaging of regulated gene expression. Radiology 2003;228:488-92. (Pubitemid 36910092)
3. Funovics MA, Kapeller B, Hoeller C, et al. MR imaging of the her2/neu and 9.2.27 tumor antigens using immunospecific contrast agents. Magn Reson Imaging 2004;22:843-50. (Pubitemid 38962321)
4. Nahrendorf M, Jaffer FA, Kelly KA, et al. Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis. Circulation 2006;114:1504-11. (Pubitemid 44527006)
5. Böhm I, Träber F, Block W, Schild H. Molecular imaging of apoptosis and necrosis-basic principles of cell biology and use in oncology. Fortschr Röntgenstr RöFo 2006;178:263-71. (Pubitemid 43381905)
6. de Vries IJ, Lesterhuis WJ, Barentsz JO, et al. Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nat Biotechnol 2005;23:1407-13. (Pubitemid 41679393)
7. Ittrich H, Lange C, Dahnke H, et al. Labeling of mesenchymal stem cells with different superparamagnetic particles of iron oxide and detectability with MRI at 3T. Fortschr Röntgenstr RöFo 2005;177: 1151-63. (Pubitemid 41159030)
8. Daldrup-Link HE, Rudelius M, Oostendorp RA, et al. Comparison of iron oxide labeling properties of hematopoietic progenitor cells from umbilical cord blood and from peripheral blood for subsequent in vivo tracking in a xenotransplant mouse model XXX. Acad Radiol 2005;12:502-10.
9. Frangioni JV, Hajjar RJ. In vivo tracking of stem cells for clinical trials in cardiovascular disease. Circulation 2004;110:3378-83. (Pubitemid 39557503)
10. Kircher MF, Allport JR, Graves EE, et al. In vivo high resolution three-dimensional imaging of antigen-specific cytotoxic T-lymphocyte trafficking to tumors. Cancer Res 2003;63:6838-46. (Pubitemid 37322966)
11. Yeh TC, Zhang W, Ildstad ST, Ho C. In vivo dynamic MRI tracking of rat T-cells labeled with superparamagnetic iron-oxide particles. Magn Reson Med 1995;33:200-8.
12. Jendelova P, Herynek V, Urdzikova L, et al. Magnetic resonance tracking of transplanted bone marrow and embryonic stem cells labeled by iron oxide nanoparticles in rat brain and spinal cord. J Neurosci Res 2004;76:232-43. (Pubitemid 38451211)
13. Bulte JW, Kraitchman DL. Monitoring cell therapy using iron oxide MR contrast agents. Curr Pharm Biotechnol 2004;5: 567-84. (Pubitemid 39654853)
14. Agger R, Petersen MS, Petersen CC, et al. T cell homing to tumors detected by 3D-coordinated positron emission tomography and magnetic resonance imaging. J Immunother 2007;30:29-39. (Pubitemid 46052201)
15. Lewin M, Carlesso N, Tung CH, et al. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat Biotechnol 2000;18:410-4. (Pubitemid 30217528)
16. Arbab AS, Yocum GT, Rad AM, et al. Labeling of cells with ferumoxides-protamine sulfate complexes does not inhibit function or differentiation capacity of hematopoietic or mesenchymal stem cells. NMR Biomed 2005;18:553-9. (Pubitemid 43013896)
17. Arbab AS, Yocum GT, Wilson LB, et al. Comparison of transfection agents in forming complexes with ferumoxides, cell labeling efficiency, and cellular viability. Mol Imaging 2004;3:24-32.
18. Sun R, Dittrich J, Le-Huu M, et al. Physical and biological characterization of superparamagnetic iron oxide- and ultrasmall superparamagnetic iron oxide-labeled cells: a comparison. Invest Radiol 2005;40:504-13. (Pubitemid 41040687)
19. Cham CC, Lee YC, Lam H, Zhang XM, editors. Analytical method validation and instrument performance verification. Hoboken, NJ: Wiley; 2004.
20. Weissleder R. Molecular imaging: exploring the next frontier. Radiology 1999;212:609-14. (Pubitemid 29410958)
21. Metz S, Bonaterra G, Rudelius M, et al. Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro. Eur Radiol 2004;14:1851-8. (Pubitemid 39386634)
22. Daldrup-Link HE, Rudelius M, Oostendorp RA, et al. Targeting of hematopoietic progenitor cells with MR contrast agents. Radiology 2003;228:760-7. (Pubitemid 37025487)
23. Matuszewski L, Persigehl T, Wall A, et al. Cell tagging with clinically approved iron oxides: feasibility and effect of lipofection, particle size, and surface coating on labeling efficiency. Radiology 2005;235:155-61. (Pubitemid 40432249)
24. Raynal I, Prigent P, Peyramaure S, et al. Macrophage endocytosis of superparamagnetic iron oxide nanoparticles: mechanisms and comparison of ferumoxides and ferumoxtran-10. Invest Radiol 2004;39:56-63. (Pubitemid 38030177)